Virote Sriuranpong

基本信息

浏览量：42

职业迁徙

个人简介

Specialties
Medicine, Oncology (Cancer)

研究兴趣

论文共 262 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Presence of Liver Metastasis Correlated with High Tumor Abundance and Indicated Adverse Prognostic Feature in EGFR Mutation Non-Small-cell Lung Cancer Patients

Piyada Sitthideatphaiboon, Pronwasun Simseekeaw,Chinachote Teerapakpinyo,Nicha Zungsontiporn,Wariya Chintanapakdee, Itthi Itthisawatpan,Shanop Shuangshoti,Virote Sriuranpong,Thanisa Tongbai,Chanida Vinayanuwattikun

SCIENTIFIC REPORTSno. 1 (2025)

引用0浏览0WOSNATURE引用

Molecular Residual Disease Analysis of Adjuvant Osimertinib in Resected EGFR-mutated Stage IB-IIIA Non-Small-cell Lung Cancer

Nature medicine (2025)

引用0浏览0WOSNATURE引用

Long-term Impact of Anthracycline in Early-Stage Breast Cancer, Bridging of MiRNAs Profiler for Early Cardiotoxicity

Nattaya Poovorawan, Thiti Susiriwatananont,Chinachote Teerapakpinyo,Pajaree Chariyavilaskul,Piyada Sitthideatphaiboon, Luxica Jarutasnangkul,Monravee Tumkosit,Pairoj Chattranukulchai,Nonthikorn Theerasuwipakorn,Chatchawit Aporntewan,Shanop Shuangshoti,Sopark Manasnayakorn,Chanida Vinayanuwattikun,Yongkasem Vorasettakarnkij,Virote Sriuranpong

Cardio-Oncologyno. 1 (2025): 1-11

引用0浏览0WOS引用

Exploring Prognostic Factors and Survival Outcomes in Advanced Non-Small Cell Lung Cancer Patients Undergoing First-Line Chemotherapy in Limited-Resource Settings

Chawalit Chayangsu,Jiraporn Khorana,Chaiyut Charoentum,Virote Sriuranpong,Jayanton Patumanond,Apichat Tantraworasin

JOURNAL OF CLINICAL MEDICINEno. 2 (2025)

引用0浏览0WOS引用

Cemiplimab Monotherapy As First-Line Treatment of Patients with Brain Metastases from Advanced Non-Small Cell Lung Cancer with Programmed Cell Death-Ligand 1 ≥50

Saadettin Kilickap,Mustafa Özgüroğlu,Ahmet Sezer,Mahmut Gümüş,Igor Bondarenko, Miranda Gogishvili, Haci M Turk,Irfan Cicin,Dmitry Bentsion, Oleg Gladkov,Virote Sriuranpong,Ruben G W Quek,Debra A G McIntyre, Xuanyao He,Jennifer McGinniss,Frank Seebach, Giuseppe Gullo,Petra Rietschel,Jean-Francois Pouliot

Cancerno. 10 (2025): e35864-e35864

引用0浏览0WOS引用

The Double-Blind Placebo-Controlled Study Comparing Upfront and Subsequent Netupitant in Addition to Olanzapine-Containing Regimen for Prevention of High-Dose Cisplatin-Induced Nausea/Vomiting

Chanida Vinayanuwattikun, Chalermchai Lertanansit, Wasamol Mahaparn, Attapol Chotirut,Nicha Zungsontiporn, Suleepon Uttamapinan, Nattaya Sintawichai,Piyada Sitthideatphaiboon,Virote Sriuranpong,Suebpong Tanasanvimon

Asia-Pacific journal of clinical oncology (2025)

引用0浏览0WOS引用

Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC

NEW ENGLAND JOURNAL OF MEDICINE (2024)

引用20浏览0WOS引用

Osimertinib after Definitive Chemoradiotherapy in Unresectable Stage III Epidermal Growth Factor Receptor-Mutated Non-Small-cell Lung Cancer: Analyses of Central Nervous System Efficacy and Distant Progression from the Phase III LAURA Study

S. Lu,M. -j. Ahn,T. Reungwetwattana,M. Oezgueroglu,T. Kato,J. c. -h. Yang, M. Huang, F. Fujiki, T. Inoue, L. -v. Quang,V. Sriuranpong,D. Vicente, C. Fuentes,A. A. Chaudhry,L. Poole,E. Armenteros Monterroso,Y. Rukazenkov,T. van der Gronde,S. S. Ramalingam

ANNALS OF ONCOLOGYno. 12 (2024): 1116-1125

引用0浏览0WOS引用

630MO First-line (1L) Osimertinib (osi) ± Platinum-Pemetrexed Chemotherapy (ctx) for EGFR-mutated (egfrm) Advanced Non-Small Cell Lung Cancer (NSCLC): FLAURA2 Asian Cohort

J.C-H. Yang, K. Kobayashi,B. Chewaskulyong, T.V. Tran,B. Biswas,K.H. Lee,P-H. Feng, X.D. Pham,Y. Yao,S. Kuyama, J.Y. Tan Chun Bing, R. Bhise,M-J. Ahn,V. Sriuranpong, R.K. Li,E. Armenteros Monterroso,K. Barrett,M. Albayaty,Y. Cheng

Annals of Oncology (2024): S1635-S1636

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

其他

论文共 262 篇作者统计合作学者相似作者